Counterweight Ventures’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Sell
2,446
-132
-5% -$48.9K 0.51% 53
2026
Q1
$698K Sell
2,578
-90
-3% -$26.8K 0.39% 57
2025
Q4
$881K Sell
2,668
-253
-9% -$85.7K 0.49% 51
2025
Q3
$1.01M Sell
2,921
-2,889
-50% -$874K 0.59% 45
2025
Q2
$1.81M Buy
5,810
+148
+3% +$56.6K 1.18% 31
2025
Q1
$2.97M Buy
5,662
+187
+3% +$95.6K 2.13% 20
2024
Q4
$2.77M Buy
5,475
+89
+2% +$50.6K 1.96% 21
2024
Q3
$3.15M Buy
5,386
+578
+12% +$327K 2.23% 19
2024
Q2
$2.45M Buy
4,808
+74
+2% +$36.3K 1.85% 24
2024
Q1
$2.34M Buy
4,734
+178
+4% +$90.5K 1.89% 23
2023
Q4
$2.4M Buy
+4,556
New +$2.43M 2.18% 19

Other funds holding UNH

Counterweight Ventures's UNH Position: Q2 2026 in Review

Counterweight Ventures reduced its UnitedHealth (UNH) stake by 5.1% in Q2 2026, selling an estimated $48.9K and leaving 2,446 shares worth $1.02M. The position accounts for 0.51% of the portfolio, ranked #53.

Counterweight Ventures first reported a position in UNH in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.15M in Q3 2024. 1,542 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Counterweight Ventures held 2,446 shares of UnitedHealth worth $1.02M as of Q2 2026.
  • Counterweight Ventures sold 132 UnitedHealth shares in Q2 2026, an estimated $48.9K.
  • UnitedHealth made up 0.51% of Counterweight Ventures's portfolio in Q2 2026, its #53 holding.
  • Counterweight Ventures first reported a position in UnitedHealth in Q4 2023 and has held it in 11 quarters since.
  • Counterweight Ventures's UnitedHealth position peaked at $3.15M in Q3 2024.
  • 1,542 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Counterweight Ventures's 13F filing for Q2 2026, filed 23 Jul 2026.